By Invitation
British politics
A former adviser to Keir Starmer on what his victory can teach the global left
You don’t have to splurge to woo back working people, says Claire Ainsley
SCOTUS and presidential immunity
Justice Sotomayor was right for the wrong reasons
The Supreme Court’s ruling on prosecuting presidents is mistaken, says Eric Nelson, but not because the founding fathers were anti-monarchists
The American election
A big donor says Joe Biden’s team has gone all Trumpian
The president is deluding himself. Democrats are better than that, says Ari Emanuel
Geopolitics
The West’s values are important, but so is realism, says Finland’s president
The Global South must be courted, even if that means compromising interests, argues Alexander Stubb
French politics
This needn’t be France’s Brexit moment, says its business envoy
Pascal Cagni explains why foreign investors should not panic
Europe’s other flashpoint
NATO must tackle instability in the Balkans, says an ex-head
Russia and China are up to old tricks in the region, argue George Robertson and Andi Hoxhaj
Business and the American election
A business leader on why he’s backing Donald Trump
The Biden administration has played dirty and shown staggering incompetence, argues Joe Lonsdale
The French election
A hard-right government might disrupt France’s relations with Europe
Or it could try to change the EU from within—which would be worse, reckons Jean Pisani-Ferry
British politics
Harriet Harman on how Parliament has changed over four decades
It is more in touch with voters, says the longest-serving female MP—but there is more work to do
Russia and the West
Vladimir Putin’s war against Ukraine is part of his revolution against the West
He is leading Russia into a new phase of strategic confrontation, says Stephen Covington, a longtime NATO adviser
Artificial intelligence
Ray Kurzweil on how AI will transform the physical world
The changes will be particularly profound in energy, manufacturing and medicine, says the futurist
Pharmaceutical innovation
What good are whizzy new drugs if the world can’t afford them?
Bringing gene therapies and obesity drugs to the masses will require financial innovation too, says Steven Pearson